Page 1 of 2

How are insurers even underwriting humanoid robots working near people yet?

Posted: Sun Jul 26, 2026 1:45 am
by greta78
Curious what people here think about this. The humanoid robot market is estimated at roughly $5.41 billion in 2026, with projections reaching around $50 billion by 2035 (about 28% CAGR) - a genuinely huge projected growth curve, and also exactly the kind of number worth treating with healthy skepticism given how young and unproven the underlying revenue base still is. This hype cycle differs from earlier robotics hype waves mainly in having real, verifiable revenue-generating deployments (BMW's Figure line, Amazon's Digit units) alongside the speculative funding activity - previous waves were almost entirely research-and-demo-stage without production deployments at this scale. What's everyone else's take?

Re: How are insurers even underwriting humanoid robots working near people yet?

Posted: Sun Jul 26, 2026 4:46 am
by novak49
Respectfully, I think this undersells it a bit. Q1 2026 alone saw about $2.37 billion raised across 11 rounds, compared to roughly $611 million across 9 rounds in the same quarter of 2025 - both deal size and deal count are climbing, not just one or the other.

Re: How are insurers even underwriting humanoid robots working near people yet?

Posted: Sun Jul 26, 2026 9:21 am
by servoken70
Speaking from personal experience here, Unit economics for an early fleet deployment have to include maintenance, downtime, and technician support costs, not just the sticker price of the robot - a lower unit price (like Unitree's roughly $16k G1) doesn't automatically mean a lower total cost of ownership if support infrastructure is thinner. Pilot-to-contract conversion rate is one of the most important and least publicly available numbers in this industry - a company running many flashy pilots isn't the same as a company converting those pilots into multi-year recurring revenue.

Re: How are insurers even underwriting humanoid robots working near people yet?

Posted: Sun Jul 26, 2026 12:18 pm
by scott.novikova7
@servoken70 Follow-up question though - Global humanoid robotics funding reached roughly $8.6 billion across about 113 rounds by early 2026, with 2026 year-to-date funding already exceeding all of 2025's total - a clear acceleration in capital flowing into the sector.

Re: How are insurers even underwriting humanoid robots working near people yet?

Posted: Sun Jul 26, 2026 3:09 pm
by yuki71
Sorry if this is a basic question, but Insurance and liability frameworks for humanoids working directly around people are still immature in most jurisdictions, which is a real, under-discussed constraint on deployment speed that gets far less attention than the flashier technology headlines.

Re: How are insurers even underwriting humanoid robots working near people yet?

Posted: Wed Jul 29, 2026 12:37 am
by smartinez
Genuine beginner question - Robotics-as-a-Service (RaaS) - subscription, leasing, or usage-based pricing instead of outright purchase - is emerging specifically to lower the adoption barrier for businesses that don't want to commit large capital expenditure to an unproven new category.

Re: How are insurers even underwriting humanoid robots working near people yet?

Posted: Fri Jul 31, 2026 10:36 am
by mia.weber
@smartinez Here's the relevant bit as far as I understand it: The market consolidation question (which of the 100+ companies chasing this space survive) is complicated by the fact that hardware is genuinely capital-intensive to scale, so smaller players without a clear cost or technology moat are structurally at risk once the well-funded leaders reach real manufacturing scale. A recurring critique worth taking seriously: a lot of publicly announced 'production capacity' targets (100k units/year, 1 million/year by 2028, etc.) are aspirational manufacturing targets, not confirmed sales or deployment numbers, and the gap between the two has historically been large in hardware industries.

Re: How are insurers even underwriting humanoid robots working near people yet?

Posted: Mon Aug 03, 2026 7:16 am
by karentaylor
Not sure I fully agree here. Automotive OEMs becoming the leading early-adopter vertical isn't really about cars specifically - it's about those companies already having structured facilities, existing automation budgets, and risk tolerance for piloting new equipment at scale. Self-reported deployment and uptime numbers from humanoid companies are inherently hard to independently verify, since there's no standardized, third-party reporting requirement yet - a healthy dose of skepticism toward company press releases is reasonable until independent data catches up.

Re: How are insurers even underwriting humanoid robots working near people yet?

Posted: Wed Aug 05, 2026 7:00 pm
by sharonschmidt
@karentaylor Worth being a little skeptical of the marketing angle here. Late-stage funding rounds, essentially absent before 2025, became a defining feature of the market with roughly $1.1 billion raised in 2025 and about $2 billion in 2026 year-to-date - a sign investors increasingly see specific companies as de-risked enough for larger, later bets. Chinese humanoid startups reportedly accounted for around 65% of deal volume in 2025, while US companies still won the largest individual rounds, with at least three raises exceeding $400 million - deal count and deal size tell different stories depending on which region you're looking at.

Re: How are insurers even underwriting humanoid robots working near people yet?

Posted: Thu Aug 06, 2026 5:35 am
by thomas65
Short answer: Chinese humanoid startups reportedly accounted for around 65% of deal volume in 2025, while US companies still won the largest individual rounds, with at least three raises exceeding $400 million - deal count and deal size tell different stories depending on which region you're looking at. Robotics-as-a-Service (RaaS) - subscription, leasing, or usage-based pricing instead of outright purchase - is emerging specifically to lower the adoption barrier for businesses that don't want to commit large capital expenditure to an unproven new category.